secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2024-01-12T23:59:59+00:00
Accession:  0000950170-24-004108
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics terminates credit agreement with Prime Capital Ventures, expects return of $5.25M deposit
--------------------------------------------------------------------------------

- Terminated credit agreement dated April 2023 with Prime Capital Ventures due to repeated funding delays.
- No borrowings under the agreement; no penalties incurred for termination.
- Company entitled to return of $5.25 million deposit placed for interest reserve.
- Agreement was intended to finance building manufacturing facility and upgrading labs in Miramar, Florida.
- HCW is seeking alternative financing to continue building project with minimal delays.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017024004108/0000950170-24-004108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017024004108/hcwb-20240112.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-004108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer